RXRX - Recursion Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RXRX is currently covered by 6 analysts with an average price target of $11.08. This is a potential upside of $5.38 (94.39%) from yesterday's end of day stock price of $5.7.

Recursion Pharmaceuticals's activity chart (see below) currently has 20 price targets and 44 ratings on display. The stock rating distribution of RXRX is 20% HOLD and 80% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60% with an average time for these price targets to be met of 48.43 days.

Highest price target for RXRX is $12, Lowest price target is $8, average price target is $11.08.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 07-Nov-2024. First documented stock forecast 11-May-2021.

Best performing analysts who are covering RXRX - Recursion Pharmaceuticals:

Gil Blum Eric Joseph Michael Ryskin Scott Schoenhaus Salveen Richter Mani Foroohar Gal Munda

Currently out of the existing stock ratings of RXRX, 5 are a HOLD (20%), 20 are a BUY (80%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$4.82 (77.99%)

$11

15 days ago
(07-Nov-2024)

2/15 (13.33%)

$4.07 (58.73%)

71

Hold

$8

$1.82 (29.45%)

$8

2 months 19 days ago
(03-Sep-2024)

4/6 (66.67%)

$1.93 (31.80%)

63

Buy

$12

$5.82 (94.17%)

$16

4 months 11 days ago
(11-Jul-2024)

2/5 (40%)

$4.32 (56.25%)

35

Hold

$10

$3.82 (61.81%)

$32

1 years 9 days ago
(13-Nov-2023)

2/2 (100%)

$4.17 (71.53%)

35

Buy

$33

$26.82 (433.98%)

$38

1 years 4 months 10 days ago
(12-Jul-2023)

0/3 (0%)

$20.92 (173.18%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?

On average it took 48.43 days on average for the stock forecasts to be realized with a an average price target met ratio 60

Which analyst has the current highest performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?

GIL BLUM

Which analyst has the current lower performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?

GAL MUNDA

Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?

Gil Blum works at NEEDHAM and has 8 price targets and 6 ratings on RXRX

Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?

Gal Munda with highest potential upside - $26.82

Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?

Mani Foroohar with lowest potential downside - $1.82

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?